01
Product-market-payer fit assessment
Is there a real buyer for this product, at this price, in this market — and is the evidence you have enough for them to act on?
Workshop:Stop building pilots.Start building funded adoption
WORKSHOP FOR MEDTECH FOUNDERS
In 3 days, ULAM LABS and ZEUMED work through your clinical problem, payer landscape, and funding timeline, side by side.
The gap shows up late
It doesn't appear during the pilot. It appears when you try to turn the pilot into a contract.
70%
of digital health pilots that show clinical benefit don't convert to paid adoption within 2 years
3 days
is all it takes to surface the gaps and build a plan — if you bring the right people to the room
1 team
engineers and reimbursement strategists, working through your product together
Your pilot worked. So why isn't anyone paying for it?
The gap is always the same: no one designed the economics in. Clinical evidence gets built for the study — not for the procurement committee. By the time that becomes obvious, you're already mid-pilot.
You have clinical traction but no one has agreed to pay yet — the beneficiary and the buyer are different organisations.
Your evidence was built for the study, not for the procurement committee — different questions, different decision-makers.
Investors ask about reimbursement and you pivot to the demo because the economic narrative isn't built yet.
Technical architecture was designed for a single site — fine for a pilot, a blocker at procurement.
Three steps. No long commitment required.
- 01
Intro call
We review your product, your pilot results, your target market, and your current funding timeline. —45 min
- 02
Discovery Workshop
ULAM LABS reviews your architecture and technical readiness. ZEUMED maps your payer landscape, evidence gaps, and reimbursement options. Both teams work through your product together. —1 day
- 03
Readout & action plan
You receive all six deliverables plus a single integrated action plan: what to fix, in what order, before your next payer conversation or funding round. No generic advice. Specific to your product, your market, your current position.
Six deliverables. One actionable plan.
01
Product-market-payer fit assessment
Is there a real buyer for this product, at this price, in this market — and is the evidence you have enough for them to act on?
02
Data gap analysis
What data you currently collect vs. what payers and procurement committees actually need. Specific gaps, specific fixes.
03
Technical readiness for procurement
Architecture review focused on the questions that come up at procurement: multi-site capability, integrations, security, data model.
04
Preliminary reimbursement strategy
Which funding route is most viable for your product in your target market and what needs to be true for it to work.
05
Evidence generation plan
What your next evidence phase should measure, how it should be structured, and what it needs to demonstrate for adoption — not just publication.
06
Investor-ready summary document
A concise document that frames your clinical evidence, adoption pathway, and economic narrative, ready to share at your next funding conversation.
02
Data gap analysis
What data you currently collect vs. what payers and procurement committees actually need. Specific gaps, specific fixes.
- Book your workshop
Ready to close the gap before it costs you a round?
3 days. Six deliverables. One integrated plan built by engineers and reimbursement strategists, side by side.
One team
We are one team that understand code, clinics, and cashflows
Software development
ULAM LABS
Custom software development, integrations, internal workflows
We build custom software and integrate existing systems so audits, submissions, and product decisions stop being bottlenecks.
Health economics
ZEUMED
Health economics, policy advisory
Health economics and policy advisory translating complex payer requirements into practical pricing, reimbursement, and value strategies for digital health and medtech.
Right timing
Three moments when the workshop pays for itself
This is the right timing to talk to us:
Before your clinical trial starts
Design your evidence strategy around what payers will actually act on — not what's easiest to measure. Changing this after the study ends is expensive.
When your MVP is almost finished
Before you've committed to an architecture that works for one site but breaks at procurement. Single-site data models and brittle EHR integrations are the two most common reasons a technically successful pilot fails its procurement review, and neither is quick to fix once the product is built.
When you're preparing to raise
Investors at Series A and beyond routinely ask: who pays for this, under which code, in which market? If the answer is still being worked out, the round slows or the valuation takes the hit instead. The workshop builds that answer before the room asks for it.
Questions teams ask before reaching out
- Who is this service for?This service is designed for medtech and digital health startups from pre‑MVP to Series A/B that need both robust software and a credible economic case. Founders, CEOs, CTOs and C‑level leaders who must convince clinicians, payers and investors will get the most value.
- What if we already have an in‑house engineering team?We can either lead end‑to‑end product development or collaborate with your existing team. In the second model, we focus on architecture, critical workflows and making sure product decisions align with evidence, pricing and reimbursement strategy.
- How does the joint ULAM Labs + Zeumed model work in practice?You get one integrated team with a single point of contact. Product, engineering and health‑economics experts join the same workshops and planning sessions, so technical scope, clinical value and economic logic are aligned from day one.
- Can you help if our product idea is not fully defined yet?Yes. We often start with teams that have a defined problem and target users, but are still shaping the exact product. We help validate use cases, map data and workflow requirements, and identify where payers and providers are most likely to see value.
- How do you support fundraising and investor conversations?We translate the product and economics work into clear decks, narratives and metrics that investors understand. This may include market sizing, value‑based pricing logic, unit economics assumptions and adoption scenarios you can confidently discuss in meetings.
Let's see if we're a good fit
No lengthy onboarding, no big commitment upfront. Book a call and we'll tell you within a week if we're the right fit.